# A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood

> **NCT04899674** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Elontril
- **DRUG:** BI 1358894

## Key facts

- **NCT ID:** NCT04899674
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-30
- **Primary completion:** 2021-09-02
- **Final completion:** 2021-09-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04899674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04899674, "A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04899674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
